Hunan Pharmaceutical Group

In 2019, the Hunan Provincial Party Committee and Provincial Government thoroughly implemented the "Healthy China" strategy and the reform of the pharmaceutical and healthcare system, pushed forward at a high level to address the problems of "high drug prices" and "expensive medical treatment," and made the "Four Ones" strategic deployment. Against this background, with the approval of the Provincial Party Committee, Provincial Government, and Provincial State-owned Assets Supervision and Administration Commission, "Hunan Pharmaceutical Group" was established. The company was officially inaugurated on November 9, 2019, with a registered capital of 1 billion yuan. It is a large provincial state-owned pharmaceutical enterprise, a provincial-level pharmaceutical reserve enterprise, a provincial-level public emergency supplies reserve enterprise, and a provincial-level pilot unit for direct settlement of medical insurance. It has been continuously rated as one of China's Top 50 Medical Device Supply Chain Enterprises and one of the National Top 100 Pharmaceutical Commercial Enterprises, etc. At present, it has 8 professional subsidiaries, 5 municipal regional subsidiaries, 2 county-level subsidiaries, and 5 branches. It has established business cooperative relationships with more than 3,000 manufacturing enterprises, with 22,000 product specifications in distribution, covering renowned manufacturers at home and abroad.
The main business of Hunan Pharmaceutical Group is the R&D, production, sales, and services of pharmaceuticals and medical device consumables; pharmaceutical industry investment and operation, pharmaceutical supply chain finance; internet pharmaceuticals and healthcare. At present, the Changsha warehousing area is 10,388.7 square meters, enabling province-wide drug delivery within 24 hours. The company has purchased 140 mu of land in Jinxia Economic Development Zone for the construction of its corporate headquarters and intelligent logistics industrial park. In the future, the company will take marketization as its principle and distribution and delivery as its entry point, accelerate its development into a regional leading enterprise, promote and drive the healthy development of the province's pharmaceutical industry, and make positive contributions to building a prosperous, beautiful, and happy new Hunan.